• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有中心性肥胖的代谢功能障碍相关脂肪性肝病与结直肠腺瘤及高危腺瘤风险增加有关。

MAFLD with central obesity is associated with increased risk of colorectal adenoma and high-risk adenoma.

作者信息

Xiong Jingfang, Wu Yijun, Chen Dongya, Zhang Zhaolin, Liu Yihui, Luo Jiandong, Xu Hong

机构信息

Department of Geriatrics, Hangzhou Red Cross Hospital, Hangzhou City, Zhejiang Province, China.

The 2nd Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou City, Zhejiang Province, China.

出版信息

BMC Gastroenterol. 2024 Apr 22;24(1):138. doi: 10.1186/s12876-024-03220-z.

DOI:10.1186/s12876-024-03220-z
PMID:38649845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11034043/
Abstract

OBJECTIVE

To analyze the risk factors associated with colorectal adenoma and to investigate the associations of metabolism-related fatty liver disease (MAFLD) with obesity, colorectal adenoma and high-risk adenoma.

METHODS

A total of 1395 subjects were enrolled and divided into a colorectal adenoma group (593 subjects) and a control group (802 subjects) according to the inclusion and exclusion criteria. The characteristics of patients in the colorectal adenoma group and the control group were compared by the chi-square test. Univariate and multivariate logistic analyses were used to analyze independent risk factors and associations with different MAFLD subtypes. Colorectal adenoma characteristics and the proportion of patients with high-risk colorectal adenoma were also compared.

RESULTS

High-density lipoprotein (HDL-C) was significantly lower in patients in the colorectal adenoma group than in those in the control group (P < 0.001). Logistic regression analysis revealed that age, obesity status, central obesity status, hypertension status, diabetes status, fatty liver status, smoking history, BMI, waist circumference, triglyceride level, HDL-C level, fasting blood glucose level and degree of hepatic steatosis were all independent risk factors for colorectal adenoma. Notably, MAFLD was associated with a significantly increased risk of colorectal adenoma in patients with central obesity (P < 0.001). In addition, obesity, central obesity, diabetes, fatty liver and degree of hepatic steatosis were all shown to be independent risk factors for high-risk colorectal adenoma. In addition, a greater proportion of MAFLD patients with central obesity than those without central obesity had high-risk colorectal adenoma.

CONCLUSION

MAFLD and central obesity are independently associated with the development of colorectal adenoma. MAFLD with central obesity is associated with an increased risk of colorectal adenoma and high-risk adenoma.

摘要

目的

分析与结直肠腺瘤相关的危险因素,并探讨代谢相关脂肪性肝病(MAFLD)与肥胖、结直肠腺瘤及高危腺瘤之间的关联。

方法

共纳入1395名受试者,根据纳入和排除标准分为结直肠腺瘤组(593名受试者)和对照组(802名受试者)。采用卡方检验比较结直肠腺瘤组和对照组患者的特征。采用单因素和多因素逻辑回归分析独立危险因素以及与不同MAFLD亚型的关联。还比较了结直肠腺瘤的特征及高危结直肠腺瘤患者的比例。

结果

结直肠腺瘤组患者的高密度脂蛋白(HDL-C)显著低于对照组(P<0.001)。逻辑回归分析显示,年龄、肥胖状态、中心性肥胖状态、高血压状态、糖尿病状态、脂肪肝状态、吸烟史、体重指数(BMI)、腰围、甘油三酯水平、HDL-C水平、空腹血糖水平及肝脂肪变性程度均为结直肠腺瘤的独立危险因素。值得注意的是,MAFLD与中心性肥胖患者患结直肠腺瘤的风险显著增加相关(P<0.001)。此外,肥胖、中心性肥胖、糖尿病、脂肪肝及肝脂肪变性程度均被证明是高危结直肠腺瘤的独立危险因素。此外,与无中心性肥胖的MAFLD患者相比,有中心性肥胖的MAFLD患者患高危结直肠腺瘤的比例更高。

结论

MAFLD和中心性肥胖与结直肠腺瘤的发生独立相关。伴有中心性肥胖的MAFLD与结直肠腺瘤及高危腺瘤风险增加相关。

相似文献

1
MAFLD with central obesity is associated with increased risk of colorectal adenoma and high-risk adenoma.伴有中心性肥胖的代谢功能障碍相关脂肪性肝病与结直肠腺瘤及高危腺瘤风险增加有关。
BMC Gastroenterol. 2024 Apr 22;24(1):138. doi: 10.1186/s12876-024-03220-z.
2
Obesity-related parameters and colorectal adenoma development.肥胖相关参数与结直肠腺瘤的发生。
J Gastroenterol. 2017 Dec;52(12):1221-1229. doi: 10.1007/s00535-017-1319-0. Epub 2017 Feb 14.
3
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.非肥胖 MAFLD 与健康检查受检者的结直肠腺瘤相关:一项多中心回顾性研究。
Int J Mol Sci. 2021 May 22;22(11):5462. doi: 10.3390/ijms22115462.
4
Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.内脏肥胖和胰岛素抵抗作为结直肠腺瘤的危险因素:一项横断面、病例对照研究。
Am J Gastroenterol. 2010 Jan;105(1):178-87. doi: 10.1038/ajg.2009.541. Epub 2009 Sep 15.
5
An association between colonic adenoma and abdominal obesity: a cross-sectional study.结肠腺瘤与腹部肥胖之间的关联:一项横断面研究。
BMC Gastroenterol. 2009 Jan 15;9:4. doi: 10.1186/1471-230X-9-4.
6
Metabolic-associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults.代谢相关脂肪性肝病与年轻和老年韩国成年人的结直肠腺瘤相关。
Liver Int. 2023 Nov;43(11):2548-2559. doi: 10.1111/liv.15738. Epub 2023 Sep 22.
7
Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study.代谢功能障碍相关脂肪性肝病、慢性肾脏病与腹型肥胖之间的关联:一项全国性回顾性队列研究。
Sci Rep. 2024 Jun 2;14(1):12645. doi: 10.1038/s41598-024-63386-0.
8
The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease.非酒精性或代谢相关脂肪性肝病患者患大肠腺瘤的风险
Biomedicines. 2021 Oct 5;9(10):1401. doi: 10.3390/biomedicines9101401.
9
Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver disease.代谢功能障碍相关脂肪性肝病女性中晚期结直肠腺瘤检出率增加。
Heliyon. 2023 Nov 16;9(11):e22391. doi: 10.1016/j.heliyon.2023.e22391. eCollection 2023 Nov.
10
Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.中心型肥胖和代谢综合征的致动脉粥样硬化性血脂异常与中国人群结直肠腺瘤风险增加相关。
BMC Gastroenterol. 2010 May 27;10:51. doi: 10.1186/1471-230X-10-51.

本文引用的文献

1
Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.结直肠癌中的免疫反应:作为预测和预后生物标志物的意义综述。
Histopathology. 2022 Dec;81(6):696-714. doi: 10.1111/his.14713. Epub 2022 Jul 15.
2
Advances in tests for colorectal cancer screening and diagnosis.结直肠癌筛查与诊断检测的进展。
Expert Rev Mol Diagn. 2022 Apr;22(4):449-460. doi: 10.1080/14737159.2022.2065197. Epub 2022 Apr 15.
3
Colorectal Cancer: Preoperative Evaluation and Staging.结直肠癌:术前评估与分期。
Surg Oncol Clin N Am. 2022 Apr;31(2):127-141. doi: 10.1016/j.soc.2021.12.001. Epub 2022 Mar 9.
4
Prevalence of Colorectal Polyps Based on Cardiorespiratory Fitness, Muscle Strength, Health Behavior, and Abdominal Obesity in Asymptomatic Elderly.基于心肺适能、肌肉力量、健康行为和腹部肥胖情况的无症状老年人结肠息肉患病率
Healthcare (Basel). 2021 Oct 19;9(10):1400. doi: 10.3390/healthcare9101400.
5
The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease.非酒精性或代谢相关脂肪性肝病患者患大肠腺瘤的风险
Biomedicines. 2021 Oct 5;9(10):1401. doi: 10.3390/biomedicines9101401.
6
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.定义儿科代谢(功能)相关脂肪性肝病:国际专家共识声明。
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):864-873. doi: 10.1016/S2468-1253(21)00183-7. Epub 2021 Aug 6.
7
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.非肥胖 MAFLD 与健康检查受检者的结直肠腺瘤相关:一项多中心回顾性研究。
Int J Mol Sci. 2021 May 22;22(11):5462. doi: 10.3390/ijms22115462.
8
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
The Clinical Significance of Colon Polyp Pathology in Nonalcoholic Fatty Liver Disease (NAFLD) and Its Impact on Screening Colonoscopy in Daily Practice.非酒精性脂肪性肝病 (NAFLD) 中结肠息肉病理的临床意义及其对日常筛查结肠镜检查的影响。
Can J Gastroenterol Hepatol. 2020 Dec 10;2020:6676294. doi: 10.1155/2020/6676294. eCollection 2020.
10
Colorectal Cancer Screening Methods and Molecular Markers for Early Detection.结直肠癌筛查方法及早期检测的分子标志物。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980426. doi: 10.1177/1533033820980426.